CorpDev.Org
Deal Intelligence Platform & Services for Global M&A / PE
Big Deal
PE Still Vital to CalPERS’ Strategy Under TPA: CEO
California Public Employees' Retirement System (CalPERS) continues to prioritize private equity as a core component of its investment portfolio, even after transitioning to a third-party administrator (TPA) model, according to its CEO. This stance...
Kraft Heinz’s New CEO Blames Private Equity Cost Cuts for Lingering Challenges
Kraft Heinz's incoming CEO has criticized the company's private equity-backed era for excessive expense reductions that undermined long-term competitiveness. This assessment highlights ongoing tensions in **post-private equity transitions** for...
ByteDance Valued at $550 Billion in Proposed Share Sale by General Atlantic, Sources Say
General Atlantic is proposing to sell a stake in ByteDance, implying a $550 billion valuation for the TikTok parent, according to sources and reports from Reuters and other outlets. Set and exceed synergy goals with benchmarks and actionable...
Danaher’s $9.9 Billion Masimo Acquisition Signals Consolidation in Patient Monitoring Technology
null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the medical device sector focused on acute care...
Warner Bros. Reopens Paramount Talks as Netflix Deal Faces Final Challenge
null Warner Bros. Discovery granted a seven-day negotiating window to engage with Paramount Skydance on its $108.4 billion acquisition offer, though the company's board continues to unanimously back Netflix's $83 billion bid for its streaming and...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline
Novo Nordisk entered a partnership worth up to $2.1 billion with Vivtex Corp. to develop next-generation oral medicines for obesity and diabetes, leveraging Vivtex's drug delivery technology to expand beyond injectable GLP-1 therapies like Wegovy. ...
GSK Secures Potential ‘Multi-Blockbuster’ Drug in $950 Million 35Pharma Acquisition
null GlaxoSmithKline announced today that it has acquired 35Pharma Inc., a Montreal-based clinical-stage biopharmaceutical company, for $950 million in cash. The deal grants GSK access to HS235, an investigational activin signaling inhibitor...
Danaher’s $9.9 Billion Masimo Acquisition Signals Consolidation in Patient Monitoring Technology
null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the medical device sector focused on acute care...
Humana Nears $1 Billion Acquisition of MaxHealth, Targets Florida Primary Care Expansion
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores Humana's strategy to deepen vertical integration...
Eli Lilly Bets $2.4 Billion on Orna Therapeutics to Advance In Vivo Cell Therapies
Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion in cash, securing access to proprietary circular RNA technology for in vivo cell engineering in autoimmune diseases and oncology. Set and exceed synergy goals with benchmarks...
